Literature DB >> 27711927

The Rising Price of Cancer Drugs-A New Old Problem?

Vinay Prasad1, Ruibin Wang2, Salma H Afifi3, Sham Mailankody4.   

Abstract

Year:  2017        PMID: 27711927     DOI: 10.1001/jamaoncol.2016.4275

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  5 in total

Review 1.  Cancer drug development: The missing links.

Authors:  Ajaikumar B Kunnumakkara; Devivasha Bordoloi; Bethsebie Lalduhsaki Sailo; Nand Kishor Roy; Krishan Kumar Thakur; Kishore Banik; Mehdi Shakibaei; Subash C Gupta; Bharat B Aggarwal
Journal:  Exp Biol Med (Maywood)       Date:  2019-04-08

Review 2.  Impact of Pharmacy Benefit Managers on Oncology Practices and Patients.

Authors:  Trevor J Royce; Caroline Schenkel; Kelsey Kirkwood; Laura Levit; Kathryn Levit; Sheetal Kircher
Journal:  JCO Oncol Pract       Date:  2020-04-20

Review 3.  Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation.

Authors:  Patricia Vella Bonanno; Michael Ermisch; Brian Godman; Antony P Martin; Jesper Van Den Bergh; Liudmila Bezmelnitsyna; Anna Bucsics; Francis Arickx; Alexander Bybau; Tomasz Bochenek; Marc van de Casteele; Eduardo Diogene; Irene Eriksson; Jurij Fürst; Mohamed Gad; Ieva Greičiūtė-Kuprijanov; Martin van der Graaff; Jolanta Gulbinovic; Jan Jones; Roberta Joppi; Marija Kalaba; Ott Laius; Irene Langner; Ileana Mardare; Vanda Markovic-Pekovic; Einar Magnusson; Oyvind Melien; Dmitry O Meshkov; Guenka I Petrova; Gisbert Selke; Catherine Sermet; Steven Simoens; Ad Schuurman; Ricardo Ramos; Jorge Rodrigues; Corinne Zara; Eva Zebedin-Brandl; Alan Haycox
Journal:  Front Pharmacol       Date:  2017-08-23       Impact factor: 5.810

4.  Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination with Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.

Authors:  Wânia Cristina da Silva; Vânia Eloisa de Araujo; Ellias Magalhães E Abreu Lima; Jessica Barreto Ribeiro Dos Santos; Michael Ruberson Ribeiro da Silva; Paulo Henrique Ribeiro Fernandes Almeida; Francisco de Assis Acurcio; Brian Godman; Amanj Kurdi; Mariângela Leal Cherchiglia; Eli Iola Gurgel Andrade
Journal:  BioDrugs       Date:  2018-12       Impact factor: 5.807

Review 5.  High-Expenditure Disease in the EU-28: Does Drug Spend Correspond to Clinical and Economic Burden in Oncology, Autoimmune Disease and Diabetes?

Authors:  Wolfgang Greiner; Keyur Patel; Christina-Jane Crossman-Barnes; Troels Vingtoft Rye-Andersen; Christian Hvid; Tom Vandebrouck
Journal:  Pharmacoecon Open       Date:  2021-01-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.